<?xml version="1.0" encoding="UTF-8"?>
<ref id="B161-pharmaceutics-12-00171">
 <label>161.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Duan</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Freeling</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Koehn</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Shu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ho</surname>
    <given-names>R.J.Y.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of Atazanavir and Darunavir Interactions with Lipids for Developing pH-Responsive Anti-HIV Drug Combination Nanoparticles</article-title>
  <source>J. Pharm. Sci.</source>
  <year>2014</year>
  <volume>103</volume>
  <fpage>2520</fpage>
  <lpage>2529</lpage>
  <pub-id pub-id-type="doi">10.1002/jps.24046</pub-id>
  <?supplied-pmid 24948204?>
  <pub-id pub-id-type="pmid">24948204</pub-id>
 </element-citation>
</ref>
